Naturopathic pain management

Alternative and Complementary Therapies

Volumn 10, Issue 4, 2004, Pages 188-193

  Barker, Jason E ^a   Meletis, Chris D ^b  

^a Hansa Research   (United States)

^b Pearl Clinic and Pharmacy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; BROMELAIN; CORYDALIS CAVA EXTRACT; DICLOFENAC; ESCHSCHOLTZIA CALIFORNICA EXTRACT; GINGER EXTRACT; GINGEROL; HERBACEOUS AGENT; PHLOGENZYM; PISCIDIA EXTRACT; PLANT EXTRACT; PROTEINASE; PROTOBERBERINE DERIVATIVE; ROTENONE; SHOGAOL; TETRAHYDROPALMATINE; UNCLASSIFIED DRUG;

ACUPUNCTURE; ALLERGIC REACTION; ALTERNATIVE MEDICINE; ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; BLADDER DISEASE; CLINICAL TRIAL; CORYDALIS; DIARRHEA; DIET THERAPY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG THERAPY; EDEMA; ELECTROSTIMULATION THERAPY; ENURESIS; ESCHSCHOLTZIA; GASTROINTESTINAL SYMPTOM; GINGER; HERBAL MEDICINE; HUMAN; HYDROTHERAPY; HYPERTENSION; INFLAMMATION; INSOMNIA; INTESTINAL SPASM; JOINT LAXITY; MEDICINAL PLANT; MESOTHERAPY; MIGRAINE; NERVE INJURY; NEURALGIA; OSTEOARTHRITIS; PAIN; PHYSICAL MEDICINE; PINEAPPLE; PISCIDIA ERYTHRINA; PROLOTHERAPY; REGENERATIVE INJECTION THERAPY; REVIEW; RHEUMATOID ARTHRITIS; SEDATION; SIDE EFFECT; SMOOTH MUSCLE SPASM; SPORT INJURY; TOOTH PAIN; TREATMENT OUTCOME; TREMOR;

EID: 3943094015     PISSN: 10762809     EISSN: None     Source Type: Journal    
DOI: 10.1089/1076280041580350     Document Type: Review

References (33)

1. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 2002;56:365-379.
2. Gallagher HJ, Daly JM. Malnutrition, injury, and the host immune response: Nutrient substitution. Curr Opin Gen Surg 1993;92-104.
3. Klein G, Kullich W. Reducing pain by oral enzyme therapy in rheumatic diseases. Wien Med Wochenschr 1999;149(21-22):577-580.
4. Hale LP, Greer PK, Sempowski GD. Bromelain treatment alters leukocyte expression of cell surface molecules involved in cellular adhesion and activation. Clin Immunol 2002;104:183-190.
5. Nettis E, Napoli G, Ferrannini A, Tursi A. IgE-mediated allergy to bromelain. Allergy 2001;56:257-258.
6. Walker AF, Bundy R, Hicks SM, Middleton RW. Bromelain reduces mild acute knee pain and improves well-being in a dose-dependent fashion in an open study of otherwise healthy adults. Phytomedicine 2002;9:681-686.
7. Tilwe GH, Beria S, Turakhia NH, Daftary GV, Schiess W. Efficacy and tolerability of oral enzyme therapy as compared to diclofenac in active osteoarthrosis of knee joint: An open randomized controlled clinical trial. J Assoc Physicians India 2001;49:617-621.
8. Kamenicek V, Holan P, Franek P. Systemic enzyme therapy in the treatment and prevention of post-traumatic and postoperative swelling. Acta Chir Orthop Traumatol Cech 2001;68:45-49.
9. Masson M. Bromelain in the treatment of blunt injuries to the musculoskeletal system: A case observation study by an orthopedic surgeon in private practice. Fortschr Med 1995;113:303-306.
10. Newall CA, Anderson LA, Philpson JD. Herbal Medicine: A Guide for Healthcare Professionals. London: The Pharmaceutical Press, 1996.
11. Kleber E, Schneider W, Schafer HL, Elstner EF. Modulation of key reactions of the catecholamine metabolism by extracts from Eschscholtzia californica and Corydalis cava. Arzneimittelforschung 1995;45:127-131.
12. Halbsguth C, Meissner O, Haberlein H. Positive cooperation of protoberberine type 2 alkaloids from Corydalis cava on the GABA(A) binding site. Planta Med 2003;69:305-309.
13. Reimeier C, Schneider I, Schneider W, Schafer HL, Elstner EF. Effects of ethanolic extracts from Eschscholtzia californica and Corydalis cava on dimerization and oxidation of enkephalins. Arzneimittelforschung 1995;45:132-136.
14. Langner E, Greifenberg S, Gruenwald J. Ginger: History and use. Adv Ther 1998;15:25-44.
15. Srivastava KC, Mustafa T. Ginger (Zingiber officinale) and rheumatic disorders. Med Hypoth 1989;29:25-28.
16. Srivastava KC. Effect of onion and ginger consumption on platelet thromboxane production in humans. Leukot Essent Fatty Acids 1989;35:183-185.
17. Onogi T. Capsaicin-like effect of (6) shogaol on substance P-containing primary afferents rats: A possible mechanism of its analgesic action. Neuropharmacology 1992;31:1165-1169.
18. Altman RD, Marcussen KC. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum 2001;44:2531-2538.
19. DiPaolo S, Gesualdo E, Grandaliano G, Schena FP. High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. Am J Pathol 1996;149:2095-2106.
20. Pugliese G, Pricci F, Locuratolo N, Romeo G, Romano G, Giannini S, Cresci B, Galli G, Rotella CM, Di Mario U. Increased activity of the insulin-like growth factor system in mesangial cells cultured in high glucose conditions: Relation to glucose-enhanced extracellular matrix production. Diabetologia 1996;39:775-784.
21. Ongley MJ, Klein RG, Dorman TA, Eek BC, Hubert LJ. A new approach to the treatment of chronic low back pain. Lancet 1987;ii:143-146.
22. Murphy M, Godson C, Cannon S, Kato S, Mackenzie HS, Martin F, Brady HR. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 1999;274:5830-5834.
23. Reeves KD, Hassanein KM. Long-term effects of dextrose prolotherapy for anterior cruciate ligament laxity. Altern Ther Health Med 2003;9:58-62.
24. Reeves KD, Hassanein K. Randomized prospective double-blind placebo-controlled study of dextrose prolotherapy for knee osteoarthritis with or without ACL laxity. Altern Ther Health Med 2000;6:68-74,77-80.
25. Reeves KD, Hassanein K. Randomized, prospective, placebo-controlled double-blind study of dextrose prolotherapy for osteoarthritic thumb and finger (DIP, PIP, and trapeziometacarpal) joints: Evidence of clinical efficacy. J Altern Complement Med 2000;6:311-320.
26. Linetsky FS, Miguel R, Torres F. Treatment of cervicothoracic pain and cervicogenic headaches with regenerative injection therapy. Curr Pain Headache Rep 2004;8:41-48.
27. Yelland M, Mar C, Pirozzo S, Schoene M, Vercoe P. Prolotherapy injections for chronic low-back pain. Cochrane Database Syst Rev 2004;2:CD004059.
28. 9th International Mesotherapy Conference [held by the French Society of Mesotherapy; proceedings]. Paris, France, October 20-22, 2000.
29. Kaplan A. Marks of pain produced by four different ways of injection [in French]. Bulletin SFM 1985:in vol. 62.
30. LeCoz J. and Dupont, J.-Y. Injection in eye of the knee by way of mesotherapy provides good concentrations intra-articularly [in French]. Quotidien du Medecin, September 20, 1983.
31. Smail H. Anterior thoracic pain with vertebral origins [in French]. 9th International Mesotherapy Conference [held by the French Society of Mesotherapy; proceedings]. Paris, France, October 20-22, 2000.
32. Leah da Silva J, Mesquita ME. Evaluation results of two methods of treatment with mesotherapy for chronic degenerative rheumatic pain [in French]. 9th International Mesotherapy Conference [held by the French Society of Mesotherapy; proceedings]. Paris, France, October 20-22, 2000.
33. Messedi-Kamoun, N., Ben Salah FZ, Dziri C. Mesotherapy in the treatment of 132 cases of spinal pain matters [in French]. 9th International Mesotherapy Conference [held by the French Society of Mesotherapy; proceedings]. Paris, France, October 20-22, 2000.